Abstract
You have accessJournal of UrologyCME1 May 2022PD53-01 MOLECULAR SUBTYPING OF N-METHYL-N-NITROSOUREA (MNU) RAT MODEL OF UROTHELIAL CARCINOMA REVEALS BOTH LUMINAL AND BASAL SIGNATURES Kara Lombardo, Takahiro Yoshida, Kate Fitzgerald, Kate Johnson, David McConkey, Alok Singh, Ridwan Alam, Max Kates, Alex Baras, and Trinity Bivalacqua Kara LombardoKara Lombardo More articles by this author , Takahiro YoshidaTakahiro Yoshida More articles by this author , Kate FitzgeraldKate Fitzgerald More articles by this author , Kate JohnsonKate Johnson More articles by this author , David McConkeyDavid McConkey More articles by this author , Alok SinghAlok Singh More articles by this author , Ridwan AlamRidwan Alam More articles by this author , Max KatesMax Kates More articles by this author , Alex BarasAlex Baras More articles by this author , and Trinity BivalacquaTrinity Bivalacqua More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002630.01AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Intrinsic subtypes of urothelial carcinoma have been identified with relevant genetic alterations and distinct clinical behavior. Carcinogen induced rodent models are clinically relevant to study urothelial carcinogenesis. In the present study, we sought to identify molecular profiles of the MNU-tumor induced rat model of urothelial carcinoma and provide additional insight into how experimental pre-clinical models may parallel human non-muscle invasive bladder cancer (NMIBC). METHODS: Intravesical MNU instillations were administered in 16 Fisher female rats every other week for a total of 4 instillations. Rats were sacrificed at either 16 (n=10) or 30 (n=6) weeks after initial instillation and bladders were harvested for analysis. Pathologic staging was assessed on H&E, and IHC was performed for basal (KRT5, KRT14, p63) and luminal (CK20, FOXA1, Pparg, Gata3) markers. Bulk RNA sequencing was performed on fresh whole bladders using an Illumina Sequencing platform and cluster analyses were performed for luminal and basal markers using Rstudio. RESULTS: MNU induced development of non-invasive tumors in 10/10 (100%,3 CIS, 3 Ta, 4 T1) bladders at week 16 and 3/6 (50%,3 T1) at week 30, while 3/6 (50%, 3 T2) progressed to muscle invasive disease at week 30. IHC analysis showed retention of luminal markers CK20, FOXA1, Pparg, and Gata3 in CIS, Ta and T1 tumor cells but loss of CDK20, Pparg and Gata3 expression in T2 disease. Basal IHC markers KRT5, KRT14 and p63 were highly expressed in all stages of MNU tumors. Sequencing data show MNU tumors cluster separately from basal-like BBN murine tumors and are more closely clustered with luminal-like UPPL mice tumors when looking at luminal signature markers KRT8 and KRT18 as well as with BASE47 subtype classifier. Cluster analysis including human tumors show MNU clusters more closely with urobasal A and B subtypes which have features including elevated expression of FGFR3, CCND1, and TP63 as well as KRT5 expression (Figure 1). CONCLUSIONS: This study is the first to characterize molecular subtype of the MNU-carcinogen induced rat model of urothelial cancer revealing a complex signature of both basal and luminal markers and provides insight into guiding clinically relevant investigations aimed at improving therapies for urothelial carcinoma. Source of Funding: None © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue Supplement 5May 2022Page: e910 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Kara Lombardo More articles by this author Takahiro Yoshida More articles by this author Kate Fitzgerald More articles by this author Kate Johnson More articles by this author David McConkey More articles by this author Alok Singh More articles by this author Ridwan Alam More articles by this author Max Kates More articles by this author Alex Baras More articles by this author Trinity Bivalacqua More articles by this author Expand All Advertisement PDF DownloadLoading ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.